Effects of Erythropoietin on Blood–Brain Barrier Tight Junctions in Ischemia–Reperfusion Rats

[1]  B. Hemmer,et al.  TNF-alpha induced NFκB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells. , 2012, Cytokine.

[2]  Yunhui Liu,et al.  Specific Role of Tight Junction Proteins Claudin-5, Occludin, and ZO-1 of the Blood–Brain Barrier in a Focal Cerebral Ischemic Insult , 2011, Journal of Molecular Neuroscience.

[3]  J. Correale,et al.  Cellular Elements of the Blood-Brain Barrier , 2009, Neurochemical Research.

[4]  Hong-li Song,et al.  The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failure , 2009, BMC gastroenterology.

[5]  Karin E. Sandoval,et al.  Blood-brain barrier tight junction permeability and ischemic stroke , 2008, Neurobiology of Disease.

[6]  J. Piontek,et al.  Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Ling Wei,et al.  Erythropoietin-Induced Neurovascular Protection, Angiogenesis, and Cerebral Blood Flow Restoration after Focal Ischemia in Mice , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  G. Üzüm,et al.  The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats. , 2007, Life sciences.

[9]  W. Jelkmann.  Erythropoietin after a century of research: younger than ever , 2007, European journal of haematology.

[10]  T. Terasaki,et al.  Exogenous expression of claudin‐5 induces barrier properties in cultured rat brain capillary endothelial cells , 2007, Journal of cellular physiology.

[11]  A. Cerami,et al.  Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. , 2006, Kidney international.

[12]  H. Ehrenreich,et al.  The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease , 2006, Journal of neurosurgical anesthesiology.

[13]  E. Ozer,et al.  Erythropoietin Downregulates Bax and DP5 ProApoptotic Gene Expression in Neonatal Hypoxic-Ischemic Brain Injury , 2006, Neonatology.

[14]  Osamu Fujiwara,et al.  Lack of effects of 1439 MHz electromagnetic near field exposure on the blood–brain barrier in immature and young rats , 2005, Bioelectromagnetics.

[15]  H. H. Marti,et al.  Erythropoietin and the hypoxic brain , 2004, Journal of Experimental Biology.

[16]  A. Pedram,et al.  TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation , 2004 .

[17]  A. Naren,et al.  Role of Phosphatidylinositol 3-Kinase in Oxidative Stress-induced Disruption of Tight Junctions* , 2003, Journal of Biological Chemistry.

[18]  S. Vilaró,et al.  Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability , 2003, The European journal of neuroscience.

[19]  M. Osanai,et al.  Tight junctions and human diseases , 2003, Medical Electron Microscopy.

[20]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[21]  Kazuki Sato,et al.  Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia* , 2001, The Journal of Biological Chemistry.

[22]  Hyun B Choi,et al.  Erythropoietin and Erythropoietin Receptors in Human CNS Neurons, Astrocytes, Microglia, and Oligodendrocytes Grown in Culture , 2001, Journal of neuropathology and experimental neurology.

[23]  W. Brück,et al.  Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain , 2001, Acta Neuropathologica.

[24]  J. Saavedra,et al.  Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. , 2000, Stroke.

[25]  H. Mohrenweiser,et al.  Production and processing of erythropoietin receptor transcripts in brain. , 2000, Brain research. Molecular brain research.

[26]  P Ghezzi,et al.  Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Ikeda,et al.  Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion , 2000, Brain Research.

[28]  E. Preston,et al.  Biphasic Opening of the Blood-Brain Barrier Following Transient Focal Ischemia: Effects of Hypothermia , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[29]  E. Mackenzie,et al.  A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  W. Hacke,et al.  'Malignant' middle cerebral artery territory infarction : Clinical course and prognostic signs , 1996 .

[31]  J. Pachter,et al.  Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro , 1995, Brain Research.

[32]  K. Hossmann.  Ischemia-mediated neuronal injury. , 1993, Resuscitation.

[33]  R. Busto,et al.  Changes in Amino Acid Neurotransmitters and Cerebral Blood Flow in the Ischemic Penumbral Region following Middle Cerebral Artery Occlusion in the Rat: Correlation with Histopathology , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  M. Ogle,et al.  Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice. , 2008, Acta neurochirurgica. Supplement.

[35]  A. Pedram,et al.  TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[36]  T. Kuroiwa,et al.  The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion , 2004, Acta Neuropathologica.

[37]  島倉 啓.  Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion , 2002 .

[38]  G. D. del Zoppo.  Microvascular changes during cerebral ischemia and reperfusion. , 1994, Cerebrovascular and brain metabolism reviews.

[39]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.